semaglutide alzheimer's GLP-1 drugs like Ozempic might help clear disease plaques, new review suggests Semaglutide's Setback in Alzheimer Disease

The anti-inflammatory properties of both peptides may contribute to joint health maintenance through reduction of inflammatory mediators that contribute to cartilage breakdown

This approach isn't used in clinical trials but is practised by some prescribers, particularly with compounded retatrutide

Franchi F, Yaranov DM, Rollini F, Rivas A, Rivas Rios J, Been L, Tani Y, Tokuda M, Iida T, Hayashi N, Angiolillo DJ, Mooradian AD

Cells shift toward greater reliance on oxidant energy production

Reports from the FDA have linked medications like exenatide to altered kidney function, particularly in patients with additional risk factors such as nephrotoxic drugs and hypertension